A Prospective Observational Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus
Stopped Terminated to allow continued optimization of the product.
Conditions
Interventions
- DEVICE: PaQ® Insulin Delivery Device
Sponsor
CeQur Corporation